Michelle Mc Murry Heath is Director of Bioventus Inc.. Currently has a direct ownership of 48,205 shares of BVS, which is worth approximately $654,623. The most recent transaction as insider was on Jun 16, 2024, when has been sold 386 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 48.2K
0% 3M change
176.74% 12M change
Total Value Held $654,623

Michelle McMurry-Heath Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 16 2024
BUY
Exercise of conversion of derivative security
-
386 Added 0.79%
48,205 Class A Common Stock
Jun 07 2024
BUY
Exercise of conversion of derivative security
-
30,400 Added 38.87%
47,819 Class A Common Stock
Jun 16 2023
BUY
Exercise of conversion of derivative security
-
386 Added 2.17%
17,419 Class A Common Stock
Jun 06 2023
BUY
Exercise of conversion of derivative security
-
16,648 Added 49.43%
17,033 Class A Common Stock
Jun 16 2022
BUY
Exercise of conversion of derivative security
-
385 Added 50.0%
385 Class A Common Stock

Also insider at

PKI
PERKINELMER INC Healthcare
MM

Michelle Mc Murry Heath

Director
Waltham, MA

Track Institutional and Insider Activities on BVS

Follow Bioventus Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BVS shares.

Notify only if

Insider Trading

Get notified when an Bioventus Inc. insider buys or sells BVS shares.

Notify only if

News

Receive news related to Bioventus Inc.

Track Activities on BVS